NZ594730A - Phosphate adsorbent comprising calcium, magnesium and iron salts for the treatment of chronic kidney deficiency and/or haemodialysis patients - Google Patents
Phosphate adsorbent comprising calcium, magnesium and iron salts for the treatment of chronic kidney deficiency and/or haemodialysis patientsInfo
- Publication number
- NZ594730A NZ594730A NZ594730A NZ59473010A NZ594730A NZ 594730 A NZ594730 A NZ 594730A NZ 594730 A NZ594730 A NZ 594730A NZ 59473010 A NZ59473010 A NZ 59473010A NZ 594730 A NZ594730 A NZ 594730A
- Authority
- NZ
- New Zealand
- Prior art keywords
- treatment
- magnesium
- calcium
- chronic kidney
- kidney deficiency
- Prior art date
Links
- 229910019142 PO4 Inorganic materials 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 230000007812 deficiency Effects 0.000 title abstract 2
- 238000001631 haemodialysis Methods 0.000 title abstract 2
- 159000000014 iron salts Chemical class 0.000 title abstract 2
- 210000003734 kidney Anatomy 0.000 title abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title abstract 2
- 239000010452 phosphate Substances 0.000 title abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title 1
- 239000003463 adsorbent Substances 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 229910052749 magnesium Inorganic materials 0.000 title 1
- 239000011777 magnesium Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 201000005991 hyperphosphatemia Diseases 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000006069 physical mixture Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09154107 | 2009-03-02 | ||
| PCT/EP2010/052551 WO2010100112A1 (en) | 2009-03-02 | 2010-03-01 | Phosphate adsorbent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ594730A true NZ594730A (en) | 2013-06-28 |
Family
ID=40627528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ594730A NZ594730A (en) | 2009-03-02 | 2010-03-01 | Phosphate adsorbent comprising calcium, magnesium and iron salts for the treatment of chronic kidney deficiency and/or haemodialysis patients |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20120052135A1 (enExample) |
| EP (1) | EP2403506A1 (enExample) |
| JP (1) | JP2012519201A (enExample) |
| KR (1) | KR101497003B1 (enExample) |
| CN (1) | CN102341111A (enExample) |
| AR (1) | AR076070A1 (enExample) |
| AU (1) | AU2010220396B2 (enExample) |
| BR (1) | BRPI1009110A2 (enExample) |
| CA (1) | CA2753364A1 (enExample) |
| CL (1) | CL2011002130A1 (enExample) |
| IL (1) | IL214509A0 (enExample) |
| MX (1) | MX2011009144A (enExample) |
| MY (1) | MY162484A (enExample) |
| NZ (1) | NZ594730A (enExample) |
| PE (1) | PE20120327A1 (enExample) |
| RU (1) | RU2527682C2 (enExample) |
| SG (1) | SG173887A1 (enExample) |
| TW (1) | TWI454267B (enExample) |
| WO (1) | WO2010100112A1 (enExample) |
| ZA (1) | ZA201106305B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0913525D0 (en) * | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
| EP2548562A1 (de) | 2011-07-18 | 2013-01-23 | SeBo GmbH | Kombinationstherapie mit Eisen-basierenden Phosphatadsorbern |
| CN105007759B (zh) * | 2013-03-08 | 2018-11-20 | 上海礼邦医药科技有限公司 | 金属离子-功能性纤维组分络合物组合物、其制备及用途 |
| EP2805603B1 (de) * | 2013-05-22 | 2017-01-11 | CLAAS E-Systems KGaA mbH & Co KG | Vorrichtung und Verfahren zur Überwachung der Schneidenschärfe |
| WO2015181205A1 (en) | 2014-05-28 | 2015-12-03 | Biaqua B.V. | Method for removing phosphate from water fractions |
| CN105232767A (zh) * | 2015-09-29 | 2016-01-13 | 江苏锦宇环境工程有限公司 | 一种制备吸附磷酸盐的药物制剂的方法 |
| CN107397758A (zh) * | 2016-05-19 | 2017-11-28 | 欣凯医药化工中间体（上海）有限公司 | 一种磷结合剂及其制备方法 |
| CN107397760B (zh) * | 2016-05-19 | 2021-07-30 | 欣凯医药化工中间体（上海）有限公司 | 基于铁的氢氧化物－低分子量糖的磷结合剂、其制备方法及其应用 |
| EP3631472B1 (en) | 2017-05-31 | 2022-07-13 | Mars, Incorporated | Methods of diagnosing and treating chronic kidney disease |
| SI3930686T1 (sl) | 2019-02-28 | 2023-11-30 | Renibus Therapeutics, Inc. | Novi železovi sestavki ter metode njihove izdelave in uporabe |
| US20210130251A1 (en) * | 2019-07-17 | 2021-05-06 | Water Warriors Inc. | Adsorbent Structures for the Removal of Phosphates and Ammonia from Wastewater and Methods of Use |
| CN114126402A (zh) * | 2019-07-23 | 2022-03-01 | 雀巢产品有限公司 | 具有针对猫科动物的肾脏有益效果的方法和组合物 |
| CN113029978A (zh) * | 2019-12-25 | 2021-06-25 | 远大生命科学(辽宁)有限公司 | 一种检测含镧试剂的磷结合能力的方法 |
| CN111905736B (zh) * | 2020-07-23 | 2021-10-26 | 安徽工业大学 | 一种半胱氨酸功能化改性的羟基氧化铁、电催化剂、制备方法及应用 |
| WO2025176793A1 (en) * | 2024-02-21 | 2025-08-28 | Mars, Incorporated | Food composition for treating mineral bone disorder |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4970079A (en) * | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
| DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
| GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| DE19917705C1 (de) * | 1999-04-20 | 2000-12-28 | Vitasyn Gmbh | Mittel zur Therapie von Hyperphosphatämie |
| DE102004031181A1 (de) * | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
| MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| EP2918548A1 (en) * | 2006-12-14 | 2015-09-16 | Novartis Tiergesundheit AG | Iron(iii) sugar based phosphate adsorbent |
-
2010
- 2010-03-01 US US13/202,586 patent/US20120052135A1/en not_active Abandoned
- 2010-03-01 NZ NZ594730A patent/NZ594730A/xx not_active IP Right Cessation
- 2010-03-01 CN CN2010800106646A patent/CN102341111A/zh active Pending
- 2010-03-01 BR BRPI1009110A patent/BRPI1009110A2/pt not_active IP Right Cessation
- 2010-03-01 AR ARP100100600A patent/AR076070A1/es not_active Application Discontinuation
- 2010-03-01 TW TW099105799A patent/TWI454267B/zh not_active IP Right Cessation
- 2010-03-01 SG SG2011062239A patent/SG173887A1/en unknown
- 2010-03-01 AU AU2010220396A patent/AU2010220396B2/en not_active Ceased
- 2010-03-01 MY MYPI2011004105A patent/MY162484A/en unknown
- 2010-03-01 JP JP2011552406A patent/JP2012519201A/ja active Pending
- 2010-03-01 WO PCT/EP2010/052551 patent/WO2010100112A1/en not_active Ceased
- 2010-03-01 MX MX2011009144A patent/MX2011009144A/es unknown
- 2010-03-01 RU RU2011140017/15A patent/RU2527682C2/ru not_active IP Right Cessation
- 2010-03-01 PE PE2011001569A patent/PE20120327A1/es not_active Application Discontinuation
- 2010-03-01 CA CA2753364A patent/CA2753364A1/en not_active Abandoned
- 2010-03-01 KR KR20117023162A patent/KR101497003B1/ko not_active Expired - Fee Related
- 2010-03-01 EP EP10705883A patent/EP2403506A1/en not_active Withdrawn
-
2011
- 2011-08-08 IL IL214509A patent/IL214509A0/en unknown
- 2011-08-26 ZA ZA2011/06305A patent/ZA201106305B/en unknown
- 2011-09-01 CL CL2011002130A patent/CL2011002130A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2011140017A (ru) | 2013-04-10 |
| RU2527682C2 (ru) | 2014-09-10 |
| MY162484A (en) | 2017-06-15 |
| MX2011009144A (es) | 2011-09-15 |
| TWI454267B (zh) | 2014-10-01 |
| IL214509A0 (en) | 2011-09-27 |
| AR076070A1 (es) | 2011-05-18 |
| US20120052135A1 (en) | 2012-03-01 |
| ZA201106305B (en) | 2012-05-30 |
| JP2012519201A (ja) | 2012-08-23 |
| WO2010100112A1 (en) | 2010-09-10 |
| KR101497003B1 (ko) | 2015-02-27 |
| TW201034677A (en) | 2010-10-01 |
| CN102341111A (zh) | 2012-02-01 |
| CL2011002130A1 (es) | 2012-03-23 |
| CA2753364A1 (en) | 2010-09-10 |
| BRPI1009110A2 (pt) | 2019-09-24 |
| AU2010220396A1 (en) | 2011-09-01 |
| AU2010220396B2 (en) | 2013-10-17 |
| KR20110128329A (ko) | 2011-11-29 |
| EP2403506A1 (en) | 2012-01-11 |
| SG173887A1 (en) | 2011-10-28 |
| PE20120327A1 (es) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ594730A (en) | Phosphate adsorbent comprising calcium, magnesium and iron salts for the treatment of chronic kidney deficiency and/or haemodialysis patients | |
| IL193099A (en) | Use of ferric citrate-containing preparations in the preparation of chronic kidney disease drugs | |
| IL221795B (en) | Use of a pharmaceutical preparation of methylnaltrexone or a salt thereof for the preparation of a medicine for the treatment of side effects of treatment with opiates | |
| NZ599928A (en) | Use of pentosan polysulfate for treatment or prophylaxis of asthma | |
| JP2012519201A5 (enExample) | ||
| DK201270445A (en) | Components for medical circuits | |
| MX2009009318A (es) | Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea. | |
| NZ607189A (en) | Materials and methods for improving gastrointestinal function | |
| EP2671584A3 (en) | Compositions and methods for treating disorders associated with salt or fluid retention | |
| EP2444491A3 (en) | Hyperglycosylated human coagulation factor IX | |
| MX340822B (es) | Formulaciones para suministro oral de adsorbentes en el intestino. | |
| IL180565A0 (en) | An improved stopcock for administering medicaments into the patient's body | |
| SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| NZ598145A (en) | Folate-targeted diagnostics and treatment | |
| MY167387A (en) | Orally administered adsorbent | |
| EA201300053A1 (ru) | Фосфатсвязывающий препарат для удобного приема | |
| PH12013500559A1 (en) | Combination therapy for treating hcv infection | |
| NZ593475A (en) | Calcium salts for reducing exhalation of infectious bioaerosol particles | |
| WO2012092305A3 (en) | Nanonized iron compositions and methods of use thereof | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| EP2106260A4 (en) | INSULIN SENSITIZERS AND TREATMENT PROCEDURES THEREWITH | |
| PL2640364T3 (pl) | Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych | |
| PT1670489E (pt) | Utilização de xénon com hipotermia para o tratamento de asfixia neonatal | |
| MY146657A (en) | Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas | |
| WO2012040164A3 (en) | Tlr5 ligands, therapeutic methods, and compositions related thereto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 01 MAR 2017 BY CPA GLOBAL Effective date: 20140206 |
|
| LAPS | Patent lapsed |